Healthcare Providers and Services
Company Overview of Opmedic Group Inc.
OPMEDIC Group Inc. provides healthcare related services primarily in Canada. It offers professional fertility services; laboratory and genetic services; diagnostic laboratory services, primarily prenatal screening; cytogenic tests designed to improve healthcare as an aid to prenatal screening and can be performed on peripheral blood, amniotic fluid, and bone marrow; and other cytology and genetic testing. The company also provides surgical and endoscopic services, such as general surgery, otorhinolaryngology, gynecology, urology, digestive endoscopy, and plastic and cosmetic surgery; and facilities for patients and surgeons. In addition, it offers sperm banking services. The company was form...
1361, Beaumont Avenue
Mount-Royal, QC H3P 2W3
Founded in 2001
Key Executives for Opmedic Group Inc.
Chief Executive Officer, President and Director
Group Chief Financial Officer and Vice President of Finance
Chief Operating Officer and Vice President of Business Development
Medical Director of Procrea Clinics and Director
Compensation as of Fiscal Year 2014.
Opmedic Group Inc. Key Developments
Opmedic Group Inc., Special/Extraordinary Shareholders Meeting, Nov 01, 2013
Sep 26 13
Opmedic Group Inc., Special/Extraordinary Shareholders Meeting, Nov 01, 2013., at 09:00 US Eastern Standard Time. Location: Norton Rose Fulbright Canada LLP. Agenda: To consider copy of which is attached as Schedule A to the accompanying management information circular dated October 3, 2013, approving (i) the amalgamation under the Business Corporations Act (Quebec) of OPMEDIC Group and Kemourmedic Acquisition Inc. all of the outstanding shares of which are owned by Drs. Pierre St-Michel, Marc Villeneuve and Jean-Yves Fontaine, substantially upon the terms and conditions set forth in the amalgamation agreement dated September 23, 2013 between OPMEDIC Group and the Purchaser, a copy of which is attached as Schedule B to the Circular, and (ii) effective immediately prior to the Amalgamation, the reduction to an aggregate amount of $1.00, without payment to Shareholders, of the issued and paid-up share capital account maintained in respect of the common shares in the share capital of OPMEDIC Group: and to transact such other business as may properly be brought before the Meeting and any postponement or adjournment.
Opmedic Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2013; Declares Cash Dividend, Payable on July 31, 2013
Jul 12 13
Opmedic Group Inc. reported earnings results for the third quarter and nine months ended May 31, 2013. For the quarter, revenue was $4.863 million, down $0.221 million or 4% from $5.084 million for the same period the previous year. Net profit and earnings per share for the quarter were respectively $0.997 million and $0.06, compared with $0.658 million and $0.04 in 2012.
For the nine months, revenues were $14.513 million, down $0.417 million or 3% from $14.930 million for the previous period. Net profit and earnings per share were respectively $2.102 million and $0.12, compared with $2.283 million and $0.13 in 2012.
Opmedic Group Inc. announced that the Board of Directors has declared a cash dividend of $0.02 per share payable on July 31, 2013 to shareholders of record at the close of business on July 24, 2013.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|